10.1016/j.cell.2023.05.003 41
Reduces inflammation and oxidative stress: BPC157 appears to downregulate proinflammatory mediators and promote nitric oxide balance, which may help with chronic pain, arthritis, and fibromyalgia. Clinically, we use BPC157 as part of programs for: Tendon and ligament injuries Muscle strains and overuse injuries Gastrointestinal disorders like IBS, Crohns disease, ulcerative colitis, and reflux Leaky gut and systemic inflammation When combined in the Wolverine Stack, BPC157 tends to provide more localized repair at the site of injury and within the gut
Novel nanomolar potency mitochondrial complex I inhibitor IACS-1131 selectively kills OXPHOS-dependent AML cells
1c, d), indicating that induction of p70S6K1 phosphorylation by inhibition of IGF-1R is independent of K-Ras or PIK3CA mutations
Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas
H., Cheng, B., Ndao, D